Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Combinatorial Chemistry & High Throughput Screening
  4. Fast Track Articles
  5. Fast Track Article
image of Exploration of the Mechanism of Tanre Qing Injection in Treating Acute Respiratory Distress Syndrome through Network Pharmacology, Molecular Docking, and Animal Experiments

Abstract

Objective

This study aimed to explore the active components and potential mechanism of Tanre Qing Injection (TRQI) in the treatment of Acute Respiratory Distress Syndrome (ARDS) using network pharmacology, molecular docking, and animal experiments.

Methods

The targets of active ingredients were identified using the TCMSP and Swiss Target Prediction databases. The targets associated with ARDS were obtained from the GeneCards database, Mala card database, and Open Targets Platform. A Protein-protein Interaction network (PPI) was constructed, and the core targets were subjected to Gene Ontology (GO) function annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Finally, molecular docking technology and a mouse model of lipopolysaccharide-induced acute lung injury validated the experimental results.

Results

The results of network pharmacology showed the active components of TRQI in the treatment of ARDS to be baicalin, chenodeoxycholic acid, oroxylin-A, and ursodeoxycholic acid, and the core targets to be TP53, ESR1, AKT1, JUN, and SRC. KEGG analysis showed 181 signaling pathways, primarily including the IL-17 signaling pathway, endocrine resistance, lipid metabolism, and atherosclerosis. Molecular docking results demonstrated that baicalin, chenodeoxycholic acid, oroxylin-A, and ursodeoxycholic acid in TRQI exhibited the strongest affinity for TP53, ESR1, and SRC. Furthermore, the results of animal experiments have indicated TRQI to have a significant inhibitory effect on inflammatory factors TNF-α, IL-1β, and IL-6, and effectively alleviate the pathological damage of ARDS to lung tissue.

Conclusion

TRQI may exert its therapeutic effects on ARDS through multiple targets and pathways, providing a research basis for its clinical application and further development.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073331156241029074305
2025-01-07
2025-03-01

  • From This Site

    /content/journals/cchts/10.2174/0113862073331156241029074305
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. He Y.Q. Zhou C.C. Yu L.Y. Wang L. Deng J. Tao Y.L. Zhang F. Chen W.S. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms. Pharmacol. Res. 2021 163 105224 10.1016/j.phrs.2020.105224 33007416
    [Google Scholar]
  2. Shaw T.D. McAuley D.F. O'Kane C.M. Emerging drugs for treating the acute respiratory distress syndrome. Expert Opin Emerg Drugs 2019 24 1 29 41 10.1080/14728214.2019.1591369
    [Google Scholar]
  3. Bos L.D.J. Ware L.B. Acute respiratory distress syndrome: Causes, pathophysiology, and phenotypes. Lancet 2022 400 10358 1145 1156 10.1016/S0140‑6736(22)01485‑4 36070787
    [Google Scholar]
  4. Luyt C.E. Bouadma L. Morris A.C. Dhanani J.A. Kollef M. Lipman J. Martin-Loeches I. Nseir S. Ranzani O.T. Roquilly A. Schmidt M. Torres A. Timsit J.F. Pulmonary infections complicating ARDS. Intensive Care Med. 2020 46 12 2168 2183 10.1007/s00134‑020‑06292‑z 33175277
    [Google Scholar]
  5. Zhang W. Zhou J.l. Application progress of pulse indicator continuous cardiac output continuous monitoring in acute respiratory distress syndrome. Contemporary Medicine. 2022 28 21 188 191
    [Google Scholar]
  6. Lu Y. Song Z. Zhou X. Huang S. Zhu D. Yang C Bai X. Sun B. Spragg R. Spragg R. A 12-month clinical survey of incidence and outcome of acute respiratory distress syndrome in Shanghai intensive care units. Intensive Care Med. 2004 30 12 2197 2203 10.1007/s00134‑004‑2479‑y 15650866
    [Google Scholar]
  7. Killien E.Y. Mills B. Watson R.S. Vavilala M.S. Rivara F.P. Morbidity and mortality among critically injured children with acute respiratory distress syndrome. Crit. Care Med. 2019 47 2 e112 e119 10.1097/CCM.0000000000003525 30379667
    [Google Scholar]
  8. Chen W. Chen Y.Y. Tsai C.F. Chen S.C.C. Lin M.S. Ware L.B. Chen C.M. Incidence and outcomes of acute respiratory distress syndrome. Medicine (Baltimore) 2015 94 43 e1849 10.1097/MD.0000000000001849 26512593
    [Google Scholar]
  9. Rubenfeld G.D. Caldwell E. Peabody E. Weaver J. Martin D.P. Neff M. Stern E.J. Hudson L.D. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005 353 16 1685 1693 10.1056/NEJMoa050333 16236739
    [Google Scholar]
  10. Bosma K.J. Lewis J.F. Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin. Emerg. Drugs 2007 12 3 461 477 10.1517/14728214.12.3.461 17874973
    [Google Scholar]
  11. Impellizzeri D. Bruschetta G. Esposito E. Cuzzocrea S. Emerging drugs for acute lung injury. Expert Opin. Emerg. Drugs 2015 20 1 75 89 10.1517/14728214.2015.1000299 25560706
    [Google Scholar]
  12. Chen L. Li J. Zhu Y. Zhao T. Guo L. Kang L. Yu J. Du H. Liu D. Weed Suppression and molecular mechanisms of isochlorogenic acid a isolated from Artemisia argyi extract via an activity-guided method. J. Agric. Food Chem. 2022 70 5 1494 1506 10.1021/acs.jafc.1c06417 35089021
    [Google Scholar]
  13. Wang L. Tao Y.L. Chen W.S. Research progress on chemical constituents, pharmacological effects and clinical application of Tanre Qing Injection. Chin. Herb. Med. 2020 51 12 3318 3328
    [Google Scholar]
  14. He B. Lu J.Y. Lin J.P. Meta-analysis of tanreqing injection in the treatment of acute lung injury / acute respiratory distress syndrome. Chinese Medicine Emergency. 2020 29 09 1552 1557
    [Google Scholar]
  15. Li G.X. Dou J. Fang Y. Bu Y.B. Xin Y. Cai Y.N. Chang Z.Z. The efficacy of statins combined with Tanre Qing Injection in the treatment of sepsis with acute lung injury and its effect on peripheral blood HMGB1, IL-6, IL-17 and IL-33. Chin J Integr Med 2021 30 16 1781 1786
    [Google Scholar]
  16. Zhao N.B. Wang D.X. Du X.H. Tanre Qing Injection in the treatment of respiratory diseases clinical application of new progress. Chinese Medicine Emergency 2018 27 4 742 f
    [Google Scholar]
  17. Wang L. Discovery and evaluation of quality markers of Tanreqing injection based on real world evidence. Shanghai University of Traditional Chinese Medicine 2021 000069
    [Google Scholar]
  18. Mann A. Early G.L. Acute respiratory distress syndrome. Mo. Med. 2012 109 5 371 375 23097941
    [Google Scholar]
  19. Xiao L.X. Deng W. Research status and evaluation of major biomarkers of acute respiratory distress syndrome. Clin. Pulm. Med. 2023 28 11 1753 1757
    [Google Scholar]
  20. Huang L. Nie L.X. Kang S. Research progress on chemical constituents, pharmacological effects and quality control of Scutellaria baicalensis. Liaoning Zhongyiyao Daxue Xuebao 2024 26 04 88 96
    [Google Scholar]
  21. Wang H. Chi Q. Xiong S.L. The effect of honeysuckle extract on lung inflammation in LPS-induced ARDS rats. Guangdong Yaoxueyuan Xuebao 2017 33 03 379 382
    [Google Scholar]
  22. Yan L. Lai Y. Effect of Tanre Qing Injection on the expression of nuclear factor-κB in lung tissue of rats with acute lung injury. Chinese Medicine Emergency 2015 24 1 38 40
    [Google Scholar]
  23. Yang L.J. Protective effect of Tanre Qing Injection on pulmonary function and vascular endothelium in acute lung injury. Chinese Journal of Experimental Prescriptions. 2013 19 07 318 320
    [Google Scholar]
  24. Mai H.Q. Clinical efficacy of Tanre Qing injection in the treatment of severe pulmonary contusion. Clin. Pulm. Med. 2017 22 06 1082 1084
    [Google Scholar]
  25. Wu W.J. Zeng N. Wang S.Y. Anti-inflammatory and lung function protective effects of baicalin on TLR4 / NF-κB signaling pathway in mice with mycoplasma pneumonia. JHI 2023 23 3521 3526
    [Google Scholar]
  26. Li X. Chang H. Shi S.L. Research progress of TCM pathogenesis and treatment of pulmonary fibrosis. Pharmacology and Clinical Practice of Traditional Chin. Med. 2021 37 01 240 247
    [Google Scholar]
  27. Li B. Wang H.M. Research progress of HMGB1 in pulmonary fibrosis after ARDS. Journal of Zunyi Medical University. 2023 46 07 725 730
    [Google Scholar]
  28. Zhang L. Xi R. Zang N.Z. Effects of Ursodeoxycholic acid on bleomycin-induced pulmonary fibrosis in rats by regulating TGF-β1 / Smads signaling pathway. World J. Tradit. Chin. Med. 2023 18 02 271 276
    [Google Scholar]
  29. Jia H. Chen X.L. Chen C. Baicalin prevents up-regulation of connective tissue growth factor in the lungs of rats with pulmonary fibrosis. Wuli Xuebao 2010 62 06 535 540 21170500
    [Google Scholar]
  30. Liao S.Y. Casanova N.G. Bime C. Camp S.M. Lynn H. Garcia J.G.N. Identification of early and intermediate biomarkers for ARDS mortality by multi-omic approaches. Sci. Rep. 2021 11 1 18874 10.1038/s41598‑021‑98053‑1 34556700
    [Google Scholar]
  31. Al-Ramli W. Préfontaine D. Chouiali F. Martin J.G. Olivenstein R. Lemière C. Hamid Q. TH17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy Clin. Immunol. 2009 123 5 1185 1187 10.1016/j.jaci.2009.02.024 19361847
    [Google Scholar]
  32. Iwakura Y. Nakae S. Saijo S. Ishigame H. The roles of IL‐17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 2008 226 1 57 79 10.1111/j.1600‑065X.2008.00699.x 19161416
    [Google Scholar]
  33. Jiang Z.Y. Wang X.N. Tang K.G. The sRNA derived from roasted licorice may alleviate lung injury in mild ADRS model mice by targeting TNF-α. Basic Medicine and Clinical. 2023 43 07 1030 1039
    [Google Scholar]
  34. Song T.R. Chen F. Dong Q.M. The anti-inflammatory effect of arctiin on ARDS cell model and the effect of PI3K-AKT-NF-кB signaling pathway. J Tradit Chin Med 2022 46 06 623 628
    [Google Scholar]
  35. Zhu L. The effect of amiloride-mediated PI3K / AKT signaling pathway on lung injury in ARDS rats. Lanzhou University 2020 10.27204/d.cnki.glzhu.2020.000517
    [Google Scholar]
  36. Shi Y. Wang Y.C. Yang Z. The effect of Xuanfei Zhisou Decoction on IL-17 signaling pathway in COPD model rats. Chinese Journal of Experimental Prescriptions. 2024 30 09 28 39 10.13422/j.cnki.syfjx.20240318
    [Google Scholar]
  37. Lin Z.W. Wu L.J. Wu H.H. To explore the mechanism of Zhishi Xiebai Guizhi Decoction in reducing myocardial injury in rats with myocardial infarction based on TNF/NF-κB signaling pathway. Chinese Journal of Experimental Prescriptions 2023 29 18 8 16 10.13422/j.cnki.syfjx.20230844
    [Google Scholar]
  38. Guo J. Zhu J. Wang Q. Wang J. Jia Y. Comparative efficacy of seven kinds of Chinese medicine injections in acute lung injury and acute respiratory distress syndrome: A network meta-analysis of randomized controlled trials. Front. Pharmacol. 2021 12 627751 10.3389/fphar.2021.627751 33767627
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073331156241029074305
Loading
Exploration of the Mechanism of Tanre Qing Injection in Treating Acute Respiratory Distress Syndrome through Network Pharmacology, Molecular Docking, and Animal Experiments
Bentham Science Publishers ; https://doi.org/10.2174/0113862073331156241029074305
/content/journals/cchts/10.2174/0113862073331156241029074305
/content/journals/cchts/10.2174/0113862073331156241029074305
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: ARDS in mice ; respiratory distress syndrome ; Tanre Qing injection ; network pharmacology ; molecular docking

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test